Identification of BRAF mutations in eruptive melanocytic nevi: new insights into melanomagenesis?

Por John, Jobin K, Smalley, Keiran SM
Publicado em 2011

The heat shock protein-90 inhibitor XL888 overcomes BRAF inhibitor resistance mediated through diverse mechanisms

Por Paraiso, Kim H. T., Haarberg, H. Eirik, Wood, Elizabeth, Rebecca, Vito W., Chen, Y. Ann, Xiang, Yun, Ribas, Antoni, Lo, Roger S., Weber, Jeffrey S., Sondak, Vernon K., John, Jobin K., Sarnaik, Amod A., Koomen, John M., Smalley, Keiran S. M.
Publicado em 2012

GSK3β inhibition blocks melanoma cell/host interactions by downregulating N-cadherin expression and decreasing FAK phosphorylation

Por John, Jobin K., Paraiso, Kim H.T., Rebecca, Vito W., Cantini, Liliana P., Abel, Ethan V., Pagano, Nicholas, Meggers, Eric, Mathew, Rahel, Krepler, Clemens, Izumi, Victoria, Fang, Bin, Koomen, John M., Messina, Jane L., Herlyn, Meenhard, Smalley, Keiran S. M.
Publicado em 2012

Ligand independent EphA2 signaling drives the adoption of a targeted therapy-mediated metastatic melanoma phenotype

Por Paraiso, Kim H. T., Thakur, Meghna Das, Fang, Bin, Koomen, John M., Fedorenko, Inna V., John, Jobin K., Tsao, Hensin, Flaherty, Keith T., Sondak, Vernon K., Messina, Jane L., Pasquale, Elena B., Villagra, Alejandro, Rao, Uma N., Kirkwood, John M., Meier, Friedegund, Sloot, Sarah, Gibney, Geoffrey T., Stuart, Darrin, Tawbi, Hussein, Smalley, Keiran S.M.
Publicado no Cancer Discov (2014)